Vice Chairman, Hong Kong Investor Relations Association
Director of Investor Relations, China Shineway Pharmaceutical Group Limited
Mr. Randy Hung is currently the Director of Investor Relations of China Shineway Pharmaceutical Group Limited (stock code: 2877). Mr. Hung has served as an executive director, independent non-executive director, and senior management of listed companies for more than 20 years. He is a fellow certified public accountant of Hong Kong, and a licensed certified public accountant of the State of California in the USA. Mr. Hung holds a MBA degree from the University of London, a Bachelor of Science degree in accounting and a certificate of programming and data processing from the University of Southern California, a certificate of China Accounting, Finance, Taxation and Law from the Chinese University of Hong Kong, and a Hong Kong Securities Institute Specialist Certificate in corporate finance. He is also serving as a council member and the Chairman of Training Committee of the Hong Kong Institute of Directors.